ArticleHealth economics review2021
COVID-19 healthcare cost and length of hospital stay in Turkey: retrospective analysis from the first peak of the pandemic.
Article in Health economics review, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Costs of inpatient care and out-of-pocket payments for COVID-19 patients: A systematic review.PloS one · 2023Pooled it
- Economic burden of COVID-19 on hospitalized patients: a cross-sectional study from Semnan, Iran.BMC health services research · 2026Article
- The economic impact of COVID-19: a comparative cost analysis of ICU hospitalizations before and during the pandemic.Clinics (Sao Paulo, Brazil) · 2026Article
- Estimating the direct medical cost of illness of COVID-19 hospitalisations in Kuwait: efficiency trade-offs from real-world data analysis.Health economics review · 2025Article
- Extended Analysis of the Hospitalization Cost and Economic Burden of COVID-19 in Romania.Healthcare (Basel, Switzerland) · 2025Article
- Article
- Cost of illness studies in COVID-19: a scoping review.Cost effectiveness and resource allocation : C/E · 2024Article
- Mechanical ventilation as a major driver of COVID-19 hospitalization costs: a costing study in a German setting.Health economics review · 2024Article
- Economic Burden of ICU-Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis.Cureus · 2023Review
- Comparison of methylprednisolone pulse vs conventional dexamethasone for adult cases of COVID-19 requiring oxygen; a Japanese retrospective cohort study.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2023Article
- Catastrophic health expenditures in hospitalized patients with delta variant of COVID-19: A cross-sectional study.Health promotion perspectives · 2023Article
- Cost-benefit analysis of Intensive Care Unit with Activity-Based Costing approach in the era COVID-19 pandemic: A case study from Iran.PloS one · 2023Article
- The implications of globalization on COVID-19 vaccination in Europe.Scientific reports · 2022Article
- Which patients bring the most costs for hospital? A study on the cost determinants among COVID-19 patients in Iran.Cost effectiveness and resource allocation : C/E · 2022Article
- COVID-19 and hospital management costs: the Italian experience.BMC health services research · 2022Article
- Hospital length of stay for COVID-19 patients: a systematic review and meta-analysis.Multidisciplinary respiratory medicine · 2022Article
- Attenuated initial serum ferritin concentration in critically ill coronavirus disease 2019 geriatric patients with comorbid psychiatric conditions.Frontiers in psychiatry · 2022Article
- Health economic burden of COVID-19 in Saudi Arabia.Frontiers in public health · 2022Article
- The Influence of Socioeconomic Status on the Prognosis and Profile of Patients Admitted for Acute Heart Failure during COVID-19 Pandemic: Overestimated Aspects or a Multifaceted Hydra of Cardiovascular Risk Factors?Healthcare (Basel, Switzerland) · 2021Article
- Estimated direct costs of COVID-19 pandemic high in Turkey, but true costs "undoubtedly higher".PharmacoEconomics & outcomes news · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDuring the COVID-19 pandemic, health care systems are under extreme pressure. This study analyzed health care resource use (HCRU) and costs in patients admitted to the hospital for COVID-19 and aimed to estimate the one-year direct medical cost of the disease in Turkey.
methodsThis retrospective cohort study was conducted between March and July 2020 in a tertiary hospital (n = 1056) in Istanbul. Patient demographics, clinical and treatment characteristics at admission, comorbidities, disease severity, and costs from a payer perspective were evaluated using the microcosting method. The results include LOS, hospital costs, and univariate and generalized linear models to investigate influencing factors. The data were extrapolated to provide a country-level estimate.
resultsThe mean length of stay was 9.1 days (SD 6.9). The mean length of stay was 8.0 days (4.7) for patients hospitalized in wards versus 14.8 days (SD 12.0) for patients hospitalized in the ICU. In univariate analysis, several factors, including O
conclusionsEstimating the impact of this pandemic in terms of HCRU and costs to the health care system can help design strategies to manage the pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.